OLDWICK, N.J., April 9, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback